Orthocell Ltd has released a press release.
Compelling 90% Success Rate for Remplir in Real World Study
Earlier from Orthocell
- Q3 FY26 Investor Presentation
- First Surgical Use of Remplir in US Department of Defense
- OCC Secures Access to 221 U.S. Military Medical Centres
- Remplir Used in 23 Surgeries in Ukrainian soldiers